Use of IL-17for maturation of oocytes

Details for Australian Patent Application No. 2005292362 (hide)

Owner Merck Serono SA

Inventors Tran, Cam Anh; Clark, Ann M.; De Matos, Daniel G.; Palmer, Stephen S.

Agent Griffith Hack

Pub. Number AU-B-2005292362

PCT Pub. Number WO2006/039592

Priority 60/614,667 30.09.04 US

Filing date 30 September 2005

Wipo publication date 13 April 2006

Acceptance publication date 31 May 2012

International Classifications

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

C12N 5/075 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Oocytes

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/039592 Priority application(s): WO2006/039592

28 June 2007 Change of Name(s) of Applicant(s), Section 104

  Applied Research Systems ARS Holding N.v. The name of the applicant has been changed to Applied Research Systems ARS Holding N.V.

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

31 May 2012 Application Accepted

  Published as AU-B-2005292362

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005292374-Use of pregnancy specific glycoprotein for maturation of oocytes

2005292358-Devices and methods for integrated continuous manufacturing of biological molecules